6XI2 image
Entry Detail
PDB ID:
6XI2
Keywords:
Title:
Apo form of POMGNT2
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2020-06-19
Release Date:
2021-04-21
Method Details:
Experimental Method:
Resolution:
2.57 Å
R-Value Free:
0.23
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2
Chain IDs:A
Chain Length:533
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2
Chain IDs:B
Chain Length:528
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2
Chain IDs:D (auth: C)
Chain Length:528
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2
Chain IDs:C (auth: D)
Chain Length:533
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA-ALA
Chain IDs:E (auth: G)
Chain Length:10
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:ALA-GLY-ALA-GLY-ALA-ALA-ALA-ALA-ALA-ALA
Chain IDs:F (auth: H)
Chain Length:10
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Crystal structures of beta-1,4-N-acetylglucosaminyltransferase 2: structural basis for inherited muscular dystrophies.
Acta Crystallogr D Struct Biol 77 486 495 (2021)
PMID: 33825709 DOI: 10.1107/S2059798321001261

Abstact

The canonical O-mannosylation pathway in humans is essential for the functional glycosylation of α-dystroglycan. Disruption of this post-translational modification pathway leads to congenital muscular dystrophies. The first committed step in the construction of a functional matriglycan structure involves the post-translational modification of α-dystroglycan. This is essential for binding extracellular matrix proteins and arenaviruses, and is catalyzed by β-1,4-N-acetylglucosaminyltransferase 2 (POMGNT2). While another glycosyl transferase, β-1,4-N-acetylglucosaminyltransferase 1 (POMGNT1), has been shown to be promiscuous in extending O-mannosylated sites, POMGNT2 has been shown to display significant primary amino-acid selectivity near the site of O-mannosylation. Moreover, several single point mutations in POMGNT2 have been identified in patients with assorted dystroglycanopathies such as Walker-Warburg syndrome and limb girdle muscular dystrophy. To gain insight into POMGNT2 function in humans, the enzyme was expressed as a soluble, secreted fusion protein by transient infection of HEK293 suspension cultures. Here, crystal structures of POMGNT2 (amino-acid residues 25-580) with and without UDP bound are reported. Consistent with a novel fold and a unique domain organization, no molecular-replacement model was available and phases were obtained through crystallization of a selenomethionine variant of the enzyme in the same space group. Tetragonal (space group P4212; unit-cell parameters a = b = 129.8, c = 81.6 Å, α = γ = β = 90°) crystals with UDP bound diffracted to 1.98 Å resolution and contained a single monomer in the asymmetric unit. Orthorhombic (space group P212121; unit-cell parameters a = 142.3, b = 153.9, c = 187.4 Å, α = γ = β = 90°) crystals were also obtained; they diffracted to 2.57 Å resolution and contained four monomers with differential glycosylation patterns and conformations. These structures provide the first rational basis for an explanation of the loss-of-function mutations and offer significant insights into the mechanics of this important human enzyme.

Legend

Protein

Chemical

Disease

Primary Citation of related structures